Regulation of prothrombinase activity by protein S

Thrombosis and Haemostasis

Volumn 82, Issue 1, 1999, Pages 80-87

  Van 'T Veer, Cornelis ^a,b   Butenas, Saulius ^a   Golden, Neal J ^a   Mann, Kenneth G ^a  

^a UNIVERSITY OF VERMONT   (United States)

^b MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR 10A; BLOOD CLOTTING FACTOR 5A; COLLAGEN; PHOSPHOLIPID; PROTEIN C; PROTEIN S; THROMBIN; THROMBOMODULIN; THROMBOPLASTIN;

ARTICLE; BINDING AFFINITY; BINDING SITE; BLOOD LEVEL; ENZYME ACTIVITY; HUMAN; PRIORITY JOURNAL; REGULATORY MECHANISM; THROMBOCYTE; THROMBOCYTE ACTIVATION;

EID: 0032774093     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0037-1614633     Document Type: Article

References (54)

1. Dahlbäck B. Protein S and C4b-binding protein: components involved in the regulation of the protein C anticoagulant system. Thromb Haemost 1991; 66: 49-61.
2. Hessing M. The interaction between complement component C4b-binding protein and the vitamin K-dependent protein S forms a link between blood coagulation and the complement system. Biochem J 1991; 277: 581-92.
3. DiScipio RG, Davie EW. Characterization of protein S, a gamma-carboxy-glutamic acid containing protein from bovine and human plasma. Biochemistry 1979; 18: 899-904.
4. Suttie JW. Vitamin K-dependent carboxylase. Annu Rev Biochem 1985; 54: 459-77.
5. Kalafatis M, Egan JO. van 't Veer C, Mann KG. Regulation and regulatory role of gamma-carboxyglutamic acid containing clotting factors. Crit Rev in Eukar Gene Expr 1996; 6: 87-101.
6. Osterud B, Rapaport SI. Activation of factor IX by the reaction product of tissue factor and factor VII. Proc Natl Acad Sci 1977; 74: 5260-4.
7. Davie EW, Fujikawa K, Kisiel W. The coagulation cascade: initiation, maintenance, and regulation. Biochemistry 1991; 30: 10363-70.
8. Mann KG, Krishnaswamy S, Lawson JH. Surface-dependent hemostasis. Hemostasis, Sem in Hematology 1992; 29: 213-27.
9. Broze GJ Jr. Tissue factor pathway inhibitor. Thromb Haemost 1995; 74: 90-936.
10. Olson ST, Björk I. Regulation of thrombin activity by antithrombin and heparin. Seminars Thromb Hemost 1994; 20: 373-409.
11. Esmon CT. Thrombomodulin as a model of molecular mechanisms that modulate protease specificity and function at the vessel wall surface. FASEB J 1995; 9: 946-55.
12. Comp PC, Esmon CT. Recurrent venous thrombosis in patients with a partial deficiency of protein S. N Engl J Med 1984; 311: 1525-8.
13. Walker FJ. Regulation of activated protein C by a new protein. A possible function for bovine protein S. J Biol Chem 1980; 255: 5521-4.
14. Walker FJ. Regulation of activated protein C by protein S. The role of phospholipid in factor Va inactivation. J Biol Chem 1981; 256: 11128-31.
15. Fulchner CA, Gardiner JE, Griffin JH, Zimmerman TS. Proteolytic inactivation of human factor VIII procoagulant protein by activated protein C and its analogy with factor V. Blood 1984; 63: 486-9.
16. Koedam JA, Meijers JCM, Sixma JJ, Bouma BN. Inactivation of human factor VIII by activated protein C. J Clin Invest 1988; 82: 1236-43.
17. Solymoss S, Tucker MM, Tracy PB. Kinetics of inactivation of membranehound factor Va by activated protein C. J Biol Chem 1988; 263:14884-90.
18. Heeb MJ, Mesters RM, Tans G, Rosing J, Griffin JH. Binding of protein S to factor Va associated with inhibition of prothrombinase that is independent of activated protein C. J Biol Chem 1993; 268: 2872-7.
19. Hackeng TM, van 't Veer C, Meijers JCM, Bouma BN. Human protein S inhibits prothrombinase complex activity on endothelial cells and platelets via direct interactions with factor Va and Xa. J Biol Chem 1994: 269: 21051-8.
20. van 't Veer C, Hackeng TM, Biesbroeck D, Sixma JJ, Bouma BN. Increased prothrombin activation in protein S-deficient plasma under flow conditions on endothelial cell matrix: an independent function of protein S in plasma. Blood 1995; 85: 1815-21.
21. Koppelman SJ, Hackeng TM, Sixma JJ, Bouma BN. Inhibition of the intrinsic factor X activating complex by protein S: evidence for a specific binding of protein S to factor VIII. Blood 1995: 86: 1062-71.
22. Heeb MJ, Rosing J, Bakker HM, Fernandez JA, Tans G, Griffin JH. Protein S binds to and inhihiLs factor Xa. Proc Natl Acad Sci USA 1994; 91: 2728-32.
23. van Wijnen M, Stam JG, van 't Veer C, Meijers JCM, Reitsma PH, Bertina RM, Bouma BN. The interaction of protein S with the phospholipid surface is essential for the activated protein C-independent activity of protein S. Thromb Haemost 1996; 76: 397-403.
24. LEIDEN. J Biol Chem 1997; 272: 20721-9.
25. Bajaj SP, Rapaport SI, Prodanos C. A simplified procedure for purification of human prothrombin, factor IX and factor X. Prep Biochem 1981; 11: 397-412.
26. van 't Veer C, Mann, KG. Regulation of tissue factor initiated thrombin generation by the stoichiometric inhibitors tissue factor pathway inhibitor. antithrombin-III and heparin cofactor-II. J Biol Chem 1997; 272: 4367-79.
27. Dahlbäck B. Purification of human vitamin K-dependent protein S and its limited proteolysis by thrombin. Biochem J 1983; 209: 837-46.
28. van 't Veer C, Golden NJ, Kalafatis M, Mann KG. Inhibitory mechanism of the protein C pathway on tissue factor-induced thrombin generation. Synergystic effect in combination with tissue factor pathway inhibitor. J Biol Chem 1997; 272: 7983-94.
29. Lu D, Xie RL, Rydzewski A, Long GL. The effect of N-linked glycosylation on molecular weight, thrombin cleavage and functional activity of human protein S. Thromb Haemost 1997; 77: 1156-63.
30. Nesheim M E, Katzmann JA, Tracy PB, Mann KG. Factor V. Meth Enzymol 1981; 80: 249-74.
31. Kane W, Majerus PW. Purification and characterization of human coagulation factor V. J Biol Chem 1981; 256: 1002-7.
32. Griffith MJ, Noyes CM, Church FC. Reactive site peptide structural similarity between heparin cofactor II and antithrombin III. J Biol Chem 1985; 260: 2218-25.
33. Barenholz. Y, Gibbs D. Litman BJ, Goll J, Thompson TE, Carlson FD. A simple method for the preparation of homogeneous phospholipid vesicles. Biochemistry 1977; 16: 2806-10.
34. Bloom JW, Nesheim ME, Mann KG. Phospholipid-binding properties of bovine factor V and factor Va. Biochemistry 1979; 18: 4419-25.
35. Leong L, Henrikse RA, Kermode JC, Rittenhouse SE, Tracy PB. The thrombin high-affinity binding site on platelets is a negative regulator of thrombin induced platelet activation. Structure-function studies using two mulant thrombins, Quick I and Quick II, Biochemistry 1992; 31: 2567-76.
36. Nesheim ME, Tracy RP, Mann KG. iClotspeedî, a mathematical simulation of the functional properties of prothrombinase. J Biol Chem 1984; 259: 1447-53.
37. Krishnaswamy S. Prothrombin complex assembly. Contributions of protein-protein and protein-membrane interactions toward complex formation. J Biol Chem 1990; 265: 3708-18.
38. Lim TK, Bloomfield VA, Nelsestuen GL. Structure of the prothrombin-and blood clotting factor X-membrane complexes. Biochemistry 1977; 16: 4177-81.
39. Higgins DL, Mann KG. The interaction of bovine factor V and factor V-derived peptides with phospholipid vesicles. J Biol Chem 1983; 258: 6503-8.
40. Zwaal RFA, Schroit AJ. Pathophysiologic implications of membrane phospholipid assymetry in blood cells. Blood 1997; 89: 1121-32.
41. Jenny RJ, Pitmann DD, Toole JJ, Kriz RW, Aldape RA, Hewick RM, Kaufmann RJ, Mann KG. Complete cDNA and derived amino acid sequence of human factor V. Proc Natl Acad Sci USA 1987; 84: 4846-50.
42. Schwalbe R, Dahlbäck B. Hillarp A, Nelsestuen G. Assembly of protein S and C4b-binding protein on membranes. J. Biol. Chem. 1990; 265: 16074-81.
43. Pieters J, Lindhout T, Hemker HC. In situ-generated thrombin is the only enzyme that effectively activates factor VIII and factor V in thromboplastin-activated plasma. Blood. 1989; 74: 1021-4.
44. Butenas S, van 't Veer C, Mann KG. Evaluation of the initiation phase of blood coagulation using ultrasensitive assays for serine proteases. J Biol Chem 1997; 272: 1527-33.
45. Marciniack E. Factor Xa inactivation by antithrombin III. Evidence for biological stabilization of factor Xa by factor V-phospholipid complex. Br J Haematol 1973; 24: 391-400.
46. Mast AE, Broze GJJr Physiological concentrations of tissue factor pathway inhibitor do not inhibit prothrombinase. Blood 1996; 87: 1845-50.
47. Tracy PB, Eide LL, Mann KG. Human prothrombinase complex assembly and function on isolated peripheral blood cell populations. J Biol Chem 1985; 260: 2119-24.
48. Krishnaswamy S, Jones KC, Mann KG. Prothromhinase complex assembly. Kinetic mechanism of enzyme assembly on phospholipid vesicles. J Biol Chem 1988; 263: 3823-34.
49. Reutelingsperger CPM, Hornstra G, Hemker HC. Isolation and partial purification of a novel anticoagulant from arteries of human umbilical cord. Eur J Biochem 1985; 151: 625-9.
50. Andree HAM, Stuart MCA, Hermens WT, Reutelingsperger CPM, Hemker HC, Frederik PM, Willems GM. Clustering of lipid-bound Annexin V may explain its anticoagulant effect. J Biol Chem 1992: 267: 17907-12.
51. van Heerde WL. Poort S, van 't Veer C. Reutelingsperger CPM, de Groot PG. Binding of recombinant annexin V to endothelial cells: effect of annexin V binding on endothelial-cell-mediated thrombin formation. Biochemical J 1994; 302: 305-12.
52. London F, Ahmad SS, Walsh PN. Annexin V inhibition of factor IXa-catalyzed factor X activation on human platelets and on negatively-charged phospholipid vesicles. Biochemistry 1996; 35: 16886-97.
53. Bouchard BA, Catcher CS, Thrash BR, Adida C, Tracy PB. Effector cell protease receptor-1, a platelet activation-dependent membrane protein, regulates prothrombinase-catalyzed thrombin generation. J Biol Chem 1997; 272: 9244-51.
54. van Wijnen M, van 't Veer C, Meijers JCM, Bertina RM, Bouma BN. A plasma coagulation assay for an activated protein C-independent anticoagulant activity of protein S. Thromb Haemost 1998; 80: 930-5.